Is On Investors’ Radar Today Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt ...

Precedence Research, a leading strategic research firm, presents a comprehensive analysis of the AI-driven bioengineering market, covering protein design, AI-guided strain engineering, generative ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

1. Long-Context Reasoning: Recursive language models (RLMs) now enable reasoning over effectively unlimited context, ...

The go-to-market AI sector has become one of the most crowded verticals in enterprise software. Companies like Gong and Clari now compete alongside dozens of well-funded startups, all pursuing the ...

On Thursday afternoon, OpenAI released a new cutting-edge coding model that the company said assisted in its own creation. “GPT-5.3-Codex is our first model that was instrumental in creating itself,” ...

The new coding model released Thursday afternoon, entitled GPT-5.3-Codex, builds on OpenAI’s GPT-5.2-Codex model and combines insights from the AI company’s GPT-5.2 model, which excels on non-coding ...

The frontier AI labs continue releasing models that are better than their predecessors, but there’s an interesting change in how they operate ...